A citation-based method for searching scientific literature

Rui D Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P P Meijerink. Haematologica 2016
Times Cited: 42







List of co-cited articles
309 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Teresa Palomero, Maria Luisa Sulis, Maria Cortina, Pedro J Real, Kelly Barnes, Maria Ciofani, Esther Caparros, Jean Buteau, Kristy Brown, Sherrie L Perkins,[...]. Nat Med 2007
672
38

The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Linda Zuurbier, Emanuel F Petricoin, Maartje J Vuerhard, Valerie Calvert, Clarissa Kooi, Jessica G C A M Buijs-Gladdines, Willem K Smits, Edwin Sonneveld, Anjo J P Veerman, Willem A Kamps,[...]. Haematologica 2012
90
26

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.
Daniel Herranz, Alberto Ambesi-Impiombato, Jessica Sudderth, Marta Sánchez-Martín, Laura Belver, Valeria Tosello, Luyao Xu, Agnieszka A Wendorff, Mireia Castillo, J Erika Haydu,[...]. Nat Med 2015
140
21

The genetics and mechanisms of T cell acute lymphoblastic leukaemia.
Laura Belver, Adolfo Ferrando. Nat Rev Cancer 2016
220
21

High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A Moreau, Stuart S Winter,[...]. Blood 2009
327
21

The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.
Teresa Palomero, Maria Dominguez, Adolfo A Ferrando. Cell Cycle 2008
182
21


The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
Yu Liu, John Easton, Ying Shao, Jamie Maciaszek, Zhaoming Wang, Mark R Wilkinson, Kelly McCastlain, Michael Edmonson, Stanley B Pounds, Lei Shi,[...]. Nat Genet 2017
443
16


PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
Rui D Mendes, Leonor M Sarmento, Kirsten Canté-Barrett, Linda Zuurbier, Jessica G C A M Buijs-Gladdines, Vanda Póvoa, Willem K Smits, Miguel Abecasis, J Andres Yunes, Edwin Sonneveld,[...]. Blood 2014
57
16

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
16


Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
P Y Jotta, M A Ganazza, A Silva, M B Viana, M J da Silva, L J G Zambaldi, J T Barata, S R Brandalise, J A Yunes. Leukemia 2010
75
14

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
C Papayannidis, D J DeAngelo, W Stock, B Huang, M N Shaik, R Cesari, X Zheng, J M Reynolds, P A English, M Ozeck,[...]. Blood Cancer J 2015
73
14

Oncogenic PTEN functions and models in T-cell malignancies.
M Tesio, A Trinquand, E Macintyre, V Asnafi. Oncogene 2016
24
20

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.
Ana Silva, J Andrés Yunes, Bruno A Cardoso, Leila R Martins, Patrícia Y Jotta, Miguel Abecasis, Alexandre E Nowill, Nick R Leslie, Angelo A Cardoso, Joao T Barata. J Clin Invest 2008
332
11

Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.
Steven M Chan, Andrew P Weng, Robert Tibshirani, Jon C Aster, Paul J Utz. Blood 2007
205
11

Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Ila Joshi, Lisa M Minter, Janice Telfer, Renée M Demarest, Anthony J Capobianco, Jon C Aster, Piotr Sicinski, Abdul Fauq, Todd E Golde, Barbara A Osborne. Blood 2009
136
11

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, Andrew P Stubbs, Eric M Vroegindeweij, Willem K Smits, Ronald van Marion, Winand N M Dinjens, Martin Horstmann, Roland P Kuiper,[...]. PLoS Med 2016
73
11

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia.
Erich Piovan, Jiyang Yu, Valeria Tosello, Daniel Herranz, Alberto Ambesi-Impiombato, Ana Carolina Da Silva, Marta Sanchez-Martin, Arianne Perez-Garcia, Isaura Rigo, Mireia Castillo,[...]. Cancer Cell 2013
172
11

The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Maddalena Paganin, Maria Francesca Grillo, Daniela Silvestri, Greta Scapinello, Barbara Buldini, Giovanni Cazzaniga, Andrea Biondi, Maria Grazia Valsecchi, Valentino Conter, Geertruij Te Kronnie,[...]. Br J Haematol 2018
24
20

PTEN: Multiple Functions in Human Malignant Tumors.
Michele Milella, Italia Falcone, Fabiana Conciatori, Ursula Cesta Incani, Anais Del Curatolo, Nicola Inzerilli, Carmen M A Nuzzo, Vanja Vaccaro, Sabrina Vari, Francesco Cognetti,[...]. Front Oncol 2015
284
9

The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
A Larson Gedman, Q Chen, S Kugel Desmoulin, Y Ge, K LaFiura, C L Haska, C Cherian, M Devidas, S B Linda, J W Taub,[...]. Leukemia 2009
105
9

NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Obul R Bandapalli, Martin Zimmermann, Corinne Kox, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Rolf Koehler, Martina U Muckenthaler, Andreas E Kulozik. Haematologica 2013
58
9


Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Amélie Trinquand, Aline Tanguy-Schmidt, Raouf Ben Abdelali, Jérôme Lambert, Kheira Beldjord, Etienne Lengliné, Noémie De Gunzburg, Dominique Payet-Bornet, Ludovic Lhermitte, Hossein Mossafa,[...]. J Clin Oncol 2013
156
9

A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Naval Daver, Yanis Boumber, Hagop Kantarjian, Farhad Ravandi, Jorge Cortes, Michael E Rytting, Jitesh D Kawedia, Jordan Basnett, Kirk S Culotta, Zhihong Zeng,[...]. Clin Cancer Res 2015
40
10

Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review).
Camilla Evangelisti, Cecilia Evangelisti, Francesca Chiarini, Annalisa Lonetti, Francesca Buontempo, Daniela Bressanin, Alessandra Cappellini, Ester Orsini, James A McCubrey, Alberto M Martelli. Int J Oncol 2014
18
22

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Konstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, Teresa Palomero, Kim de Keersmaecker, Katherine McJunkin, Johannes Zuber, Taneisha James, Aly A Khan, Christina S Leslie,[...]. Nat Cell Biol 2010
256
9

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
K Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, J C M Uitdehaag, W K Smits, J van der Zwet, R C Buijsman, G J R Zaman, R Pieters, J P P Meijerink. Leukemia 2016
63
9

Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.
Yana Pikman, Gabriela Alexe, Giovanni Roti, Amy Saur Conway, Andrew Furman, Emily S Lee, Andrew E Place, Sunkyu Kim, Chitra Saran, Rebecca Modiste,[...]. Clin Cancer Res 2017
68
9

Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
Kathleen Cullion, Kyle M Draheim, Nicole Hermance, Jennifer Tammam, Vishva M Sharma, Christopher Ware, George Nikov, Veena Krishnamoorthy, Pradip K Majumder, Michelle A Kelliher. Blood 2009
106
9


Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Sudhir S Rao, Jennifer O'Neil, Cole D Liberator, James S Hardwick, Xudong Dai, Theresa Zhang, Edyta Tyminski, Jing Yuan, Nancy E Kohl, Victoria M Richon,[...]. Cancer Res 2009
108
9

Synergistic antileukemic therapies in NOTCH1-induced T-ALL.
Marta Sanchez-Martin, Alberto Ambesi-Impiombato, Yue Qin, Daniel Herranz, Mukesh Bansal, Tiziana Girardi, Elisabeth Paietta, Martin S Tallman, Jacob M Rowe, Kim De Keersmaecker,[...]. Proc Natl Acad Sci U S A 2017
41
9

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
Jennifer O'Neil, Jonathan Grim, Peter Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James Hardwick, Markus Welcker, Jules P Meijerink, Rob Pieters,[...]. J Exp Med 2007
507
9

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
V Agnusdei, S Minuzzo, C Frasson, A Grassi, F Axelrod, S Satyal, A Gurney, T Hoey, E Seganfreddo, G Basso,[...]. Leukemia 2014
85
9

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Birgit Knoechel, Justine E Roderick, Kaylyn E Williamson, Jiang Zhu, Jens G Lohr, Matthew J Cotton, Shawn M Gillespie, Daniel Fernandez, Manching Ku, Hongfang Wang,[...]. Nat Genet 2014
244
9

Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Pedro J Real, Valeria Tosello, Teresa Palomero, Mireia Castillo, Eva Hernando, Elisa de Stanchina, Maria Luisa Sulis, Kelly Barnes, Catherine Sawai, Irene Homminga,[...]. Nat Med 2009
330
9

How I treat T-cell acute lymphoblastic leukemia in adults.
Mark R Litzow, Adolfo A Ferrando. Blood 2015
101
9

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update.
Camilla Evangelisti, Francesca Chiarini, James A McCubrey, Alberto M Martelli. Int J Mol Sci 2018
26
15

The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
Bryan King, Thomas Trimarchi, Linsey Reavie, Luyao Xu, Jasper Mullenders, Panagiotis Ntziachristos, Beatriz Aranda-Orgilles, Arianne Perez-Garcia, Junwei Shi, Christopher Vakoc,[...]. Cell 2013
226
7

The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Marta Sanchez-Martin, Adolfo Ferrando. Blood 2017
122
7

Pediatric T-cell acute lymphoblastic leukemia.
Kristina Karrman, Bertil Johansson. Genes Chromosomes Cancer 2017
65
7

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
P Richter-Pechańska, J B Kunz, J Hof, M Zimmermann, T Rausch, O R Bandapalli, E Orlova, G Scapinello, J C Sagi, M Stanulla,[...]. Blood Cancer J 2017
56
7


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Rosanna Parasole, Martin Zimmermann, Michael Dworzak, Barbara Buldini,[...]. Blood 2011
257
7

Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.
M Tesio, A Trinquand, P Ballerini, G Hypolite, L Lhermitte, A Petit, N Ifrah, A Baruchel, H Dombret, E Macintyre,[...]. Leukemia 2017
22
13

Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.
A Schwarzer, H Holtmann, M Brugman, J Meyer, C Schauerte, J Zuber, D Steinemann, B Schlegelberger, Z Li, C Baum. Oncogene 2015
21
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.